Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Faropenem in adult community-acquired bacterial pneumonia
NCT01937832Phase 3Unknown
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of faropenem in community acquired pneumonia (CAP), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Status: unknown.
02
Drugs
faropenem
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT01937832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01937832.